Literature DB >> 25971952

Phosphodiesterase 8B and cyclic AMP signaling in the adrenal cortex.

Leticia Ferro Leal1, Eva Szarek, Fabio Faucz, Constantine A Stratakis.   

Abstract

Bilateral adrenocortical hyperplasia (BAH) in humans and mice has been recently linked to phosphodiesterase (PDE) 8B (PDE8B) and 11 (PDE11A) defects. These findings have followed the discovery that defects of primary genes of the cyclic monophosphatase (cAMP) signaling pathway, such as guanine nucleotide binding alpha subunit and PRKAR1A, are involved in the pathogenesis of BAH in humans; complete absence of Prkar1a in the adrenal cortex of mice also led to pathology that mimicked the human disease. Here, we review the most recent findings in human and mouse studies on PDE8B, a cAMP-specific PDE that appears to be highly expressed in the adrenal cortex and whose deficiency may underlie predisposition to BAH and possibly other human diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25971952     DOI: 10.1007/s12020-015-0621-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  36 in total

Review 1.  The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.

Authors:  Li-Chun Lisa Tsai; Joseph A Beavo
Journal:  Curr Opin Pharmacol       Date:  2011-09-29       Impact factor: 5.547

Review 2.  [Clinical and molecular aspects of the ACTH-independent bilateral macronodular adrenal hyperplasia].

Authors:  Sonir R Antonini; Maria Cândida Fragoso; André Lacroix
Journal:  Arq Bras Endocrinol Metabol       Date:  2005-03-07

Review 3.  cAMP-dependent protein kinase: role in normal and malignant growth.

Authors:  Y S Cho-Chung; S Pepe; T Clair; A Budillon; M Nesterova
Journal:  Crit Rev Oncol Hematol       Date:  1995-11       Impact factor: 6.312

4.  E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.

Authors:  Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2014-10       Impact factor: 5.958

5.  Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours.

Authors:  Anya Rothenbuhler; Anelia Horvath; Rossella Libé; Fabio R Faucz; Amato Fratticci; Marie L Raffin Sanson; Delphine Vezzosi; Monalisa Azevedo; Isaak Levy; Madson Q Almeida; Maya Lodish; Maria Nesterova; Jérôme Bertherat; Constantine A Stratakis
Journal:  Clin Endocrinol (Oxf)       Date:  2012-08       Impact factor: 3.478

6.  Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.

Authors:  Georgette N Jones; Chhavy Tep; William H Towns; Georgeta Mihai; Ian D Tonks; Graham F Kay; Petra M Schmalbrock; Anat O Stemmer-Rachamimov; Sung Ok Yoon; Lawrence S Kirschner
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

7.  Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis.

Authors:  Zhirong Yin; Georgette N Jones; William H Towns; Xiaoli Zhang; E Dale Abel; Philip F Binkley; David Jarjoura; Lawrence S Kirschner
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

8.  Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.

Authors:  Lionel Groussin; Eric Jullian; Karine Perlemoine; Albert Louvel; Bruno Leheup; Jean Pierre Luton; Xavier Bertagna; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

9.  Cyclic AMP, protein kinase A, and phosphodiesterases: proceedings of an international workshop.

Authors:  C A Stratakis
Journal:  Horm Metab Res       Date:  2012-09-05       Impact factor: 2.936

10.  Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Authors:  Gerald Goh; Ute I Scholl; James M Healy; Murim Choi; Manju L Prasad; Carol Nelson-Williams; John W Kunstman; John W Kuntsman; Reju Korah; Anna-Carinna Suttorp; Dimo Dietrich; Matthias Haase; Holger S Willenberg; Peter Stålberg; Per Hellman; Göran Akerström; Peyman Björklund; Tobias Carling; Richard P Lifton
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

View more
  1 in total

Review 1.  Diagnosis and Clinical Genetics of Cushing Syndrome in Pediatrics.

Authors:  Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2016-06       Impact factor: 4.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.